Expeditious Entry to Functionalized Pseudo-peptidic Organoselenide Redox Modulators via Sequential Ugi/SN Methodology

Author(s): Saad Shaaban, Amr Negm, Mohamed A. Sobh, Ludger A. Wessjohann

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 16 , Issue 5 , 2016

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


An efficient route towards the synthesis of symmetrical diselenide and seleniumcontaining quinone pseudopeptides via one-pot Ugi and sequential nucleophilic substitution (SN) methodology was developed. Compounds were evaluated for their antimicrobial and anticancer activities and their corresponding antioxidant/pro-oxidant profiles were assesed employing 2,2-diphenyl-1-picrylhydrazyl (DPPH), bleomycin dependent DNA damage and glutathione peroxidase (GPx)-like activity assays. Selenium based quinones were among the most potent cytotoxic compounds with a slight preference for MCF-7 compared to HepG2 cells and good free radical scavenging activity. Furthermore, symmetrical diselenides exhibited the most potent GPx-like activity compared to ebselen. Moreover, compounds 7, 8, 9 and 10 exhibited similar antifungal activity to the antifungal drug clotrimazole with modest activity against the Gram-positive bacterium S. aureus. These results indicate that some of the synthesized organoselenides are redox modulating agent with promising anti-cancer and antifungal potentials.

Keywords: Anticancer; diselenides, diversity-oriented synthesis (DOS), glutathione peroxidase mimics, isocyanide-based multicomponent reactions (IMCR), pseudopeptides, selenium-based quinones, Ugi reaction.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 16 March, 2016
Page: [621 - 632]
Pages: 12
DOI: 10.2174/1871520615666150916092035
Price: $65

Article Metrics

PDF: 35
PRC: 1